Lockheed Martin and ZyGEM Announce Upcoming Early Release of Rapid DNA Analysis Platform for Human Identity Testing

Companies unveil key component at leading forensics science meeting

Charlottesville, Va. and Bethesda, Md., March 6, 2012 – Lockheed Martin [NYSE: LMT] and ZyGEM Corp. Ltd. announced plans to release a version of their rapid DNA analysis platform that is designed to simplify and speed DNA analysis for human identity testing. Pre-production units of the platform will be released this summer to select customers in the forensic, homeland security and intelligence communities.

The companies recently unveiled a compact cartridge device that is a key component of the rapid DNA analysis platform during the Annual Scientific Meeting of the American Academy of Forensic Sciences (AAFS).  ZyGEM and Lockheed Martin have worked together to develop the platform that uses advanced microfluidics and ZyGEM’s proprietary nucleic acid isolation technology to accelerate the DNA identification process. The team has integrated all the elements to create a compact laboratory on a single chip that significantly reduces the number of DNA processing steps and time required for analysis.

“With the successful development of our fully-integrated cartridge device, this platform now has the potential to transform today’s DNA identification process from one that takes a great deal of training, sophisticated equipment and time into a far simpler, more affordable process that can be performed in the lab or field in under 90 minutes,” said Joan Bienvenue, Ph.D., Lockheed Martin program manager and chief scientist.

During their presentation at the AAFS meeting, Bienvenue and James Landers, Ph.D., ZyGEM chief scientific officer, explained how the microfluidic cartridge can analyze multiple DNA samples accurately and rapidly, with minimal handling required.  The cartridge is designed specifically for human identification applications.  

“Unveiling this critical component of our rapid DNA analysis platform at the premier forensic science meeting of the year enabled us to receive feedback from prospective users who are eager for alternatives to the complex, time-consuming and costly options available today,” said ZyGEM Chief Executive Officer Paul Kinnon.  “The feedback was very positive, and we look forward to offering the unique capabilities of this platform on a pre-production basis.”

About ZyGEM

ZyGEM Corporation markets nucleic acid extraction solutions based on the company’s exclusive collection of microorganisms from extreme environments, with applications in basic research, forensics, clinical diagnostics and agriculture.  ZyGEM’s MicroLab unit is developing integrated sample-to-answer systems with the potential to revolutionize DNA testing.  For more information, visit www.zygem.com.

About Lockheed Martin

Headquartered in Bethesda, Md., Lockheed Martin is a global security and aerospace company that employs about 123,000 people worldwide and is principally engaged in the research, design, development, manufacture, integration and sustainment of advanced technology systems, products and services. The Corporation's net sales for 2011 were $46.5 billion. For more information, visit www.lockheedmartin.com.

 

Media Contacts:

ZyGEM:  Jennifer Anderson, 212-584-2276 x202, janderson@biocompartners.com

Lockheed Martin:  Erin Tassey, 240-477-3475, erin.tassey@lmco.com